Orchestra BioMed Holdings Inc’s filing revealed that its Director Fain Eric S unloaded Company’s shares for reported $8183.0 on Jun 26 ’25. In the deal valued at $3.05 per share,2,683 shares were sold. As a result of this transaction, Fain Eric S now holds 50,949 shares worth roughly $0.14 million.
Then, Fain Eric S bought 2,683 shares, generating $8,194 in total proceeds.
Before that, RTW INVESTMENTS, LP bought 49,900 shares. Orchestra BioMed Holdings Inc shares valued at $149,201 were divested by the 10% Owner at a price of $2.99 per share. As a result of the transaction, RTW INVESTMENTS, LP now holds 8,306,063 shares, worth roughly $23.09 million.
BTIG Research initiated its Orchestra BioMed Holdings Inc [OBIO] rating to a Buy in a research note published on March 20, 2025; the price target was $12. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. H.C. Wainwright began covering OBIO with “Buy” recommendation on August 22, 2024. B. Riley Securities started covering the stock on July 25, 2024. It rated OBIO as “a Buy”.
Price Performance Review of OBIO
On Friday, Orchestra BioMed Holdings Inc [NASDAQ:OBIO] saw its stock fall -6.71% to $2.78. Over the last five days, the stock has lost -7.64%. Orchestra BioMed Holdings Inc shares have fallen nearly -59.42% since the year began. Nevertheless, the stocks have fallen -30.50% over the past one year. While a 52-week high of $8.87 was reached on 01/02/25, a 52-week low of $2.37 was recorded on 05/07/25.
Levels Of Support And Resistance For OBIO Stock
The 24-hour chart illustrates a support level at 2.61, which if violated will result in even more drops to 2.45. On the upside, there is a resistance level at 3.01. A further resistance level may holdings at 3.25.
How much short interest is there in Orchestra BioMed Holdings Inc?
A steep rise in short interest was recorded in Orchestra BioMed Holdings Inc stocks on 2025-06-13, dropping by -0.13 million shares to a total of 1.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.19 million shares. There was a decline of -12.3%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 19, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
